Treatment Study for Articular Cartilage Injuries in the Knee
The purpose of this company-sponsored Phase 3 study is to learn about the safety and potential efficacy of the investigational cartilage tissue implant, NeoCart®, compared to microfracture, the current standard of care surgery for articular cartilage defects of the knee. A total of 245 patients will participate in the NeoCart clinical trial in up to 40 sites across the United States.
In order to participate you must meet the following criteria:
- Are able and willing to give informed consent.
- Are 18 to 59 years of age.
- Are symptomatic with knee pain indicative of an articular cartilage injury of the distal femur and/or trochlea.
This is a partial list of elgibility requirements.